These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 32780287

  • 1. NOX Inhibitors: From Bench to Naxibs to Bedside.
    Elbatreek MH, Mucke H, Schmidt HHHW.
    Handb Exp Pharmacol; 2021; 264():145-168. PubMed ID: 32780287
    [Abstract] [Full Text] [Related]

  • 2. Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation.
    Dao VT, Elbatreek MH, Altenhöfer S, Casas AI, Pachado MP, Neullens CT, Knaus UG, Schmidt HHHW.
    Free Radic Biol Med; 2020 Feb 20; 148():60-69. PubMed ID: 31883469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nox, Nox, Are You There? The Role of NADPH Oxidases in the Peripheral Nervous System.
    Eid SA, Savelieff MG, Eid AA, Feldman EL.
    Antioxid Redox Signal; 2022 Sep 20; 37(7-9):613-630. PubMed ID: 34861780
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxidants in Physiological Processes.
    Knaus UG.
    Handb Exp Pharmacol; 2021 Sep 20; 264():27-47. PubMed ID: 32767144
    [Abstract] [Full Text] [Related]

  • 9. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.
    Bedard K, Krause KH.
    Physiol Rev; 2007 Jan 20; 87(1):245-313. PubMed ID: 17237347
    [Abstract] [Full Text] [Related]

  • 10. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
    Gorin Y, Cavaglieri RC, Khazim K, Lee DY, Bruno F, Thakur S, Fanti P, Szyndralewiez C, Barnes JL, Block K, Abboud HE.
    Am J Physiol Renal Physiol; 2015 Jun 01; 308(11):F1276-87. PubMed ID: 25656366
    [Abstract] [Full Text] [Related]

  • 11. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.
    Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK.
    Circ Res; 2001 May 11; 88(9):888-94. PubMed ID: 11348997
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
    Chen F, Li X, Aquadro E, Haigh S, Zhou J, Stepp DW, Weintraub NL, Barman SA, Fulton DJR.
    Free Radic Biol Med; 2016 Oct 11; 99():167-178. PubMed ID: 27498117
    [Abstract] [Full Text] [Related]

  • 13. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.
    Frey RS, Ushio-Fukai M, Malik AB.
    Antioxid Redox Signal; 2009 Apr 11; 11(4):791-810. PubMed ID: 18783313
    [Abstract] [Full Text] [Related]

  • 14. Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.
    Rezende F, Prior KK, Löwe O, Wittig I, Strecker V, Moll F, Helfinger V, Schnütgen F, Kurrle N, Wempe F, Walter M, Zukunft S, Luck B, Fleming I, Weissmann N, Brandes RP, Schröder K.
    Free Radic Biol Med; 2017 Jan 11; 102():57-66. PubMed ID: 27863990
    [Abstract] [Full Text] [Related]

  • 15. Inhibiting NADPH Oxidases to Target Vascular and Other Pathologies: An Update on Recent Experimental and Clinical Studies.
    Sylvester AL, Zhang DX, Ran S, Zinkevich NS.
    Biomolecules; 2022 Jun 13; 12(6):. PubMed ID: 35740948
    [Abstract] [Full Text] [Related]

  • 16. Role of NOX1 and NOX5 in protein kinase C/reactive oxygen species‑mediated MMP‑9 activation and invasion in MCF‑7 breast cancer cells.
    Song HK, Kim JM, Noh EM, Youn HJ, Lee YR.
    Mol Med Rep; 2024 Oct 13; 30(4):. PubMed ID: 39219290
    [Abstract] [Full Text] [Related]

  • 17. NADPH oxidase 4 and its role in the cardiovascular system.
    Gray SP, Shah AM, Smyrnias I.
    Vasc Biol; 2019 Oct 13; 1(1):H59-H66. PubMed ID: 32923955
    [Abstract] [Full Text] [Related]

  • 18. Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".
    Dahan I, Pick E.
    Cell Mol Life Sci; 2012 Jul 13; 69(14):2283-305. PubMed ID: 22562603
    [Abstract] [Full Text] [Related]

  • 19. Methods for Detection of NOX-Derived Superoxide Radical Anion and Hydrogen Peroxide in Cells.
    Augsburger F, Filippova A, Jaquet V.
    Methods Mol Biol; 2019 Jul 13; 1982():233-241. PubMed ID: 31172475
    [Abstract] [Full Text] [Related]

  • 20. Endothelial NADPH oxidases: which NOX to target in vascular disease?
    Drummond GR, Sobey CG.
    Trends Endocrinol Metab; 2014 Sep 13; 25(9):452-63. PubMed ID: 25066192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.